HAEMONETICS CORP MASS - NOTE 2.500% 6/0

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Debt / NOTE 2.500% 6/0
Number of holders
46
Total 13F principal, excl. options
635M
Principal change
-11M
Total reported value, excl. options
$588M
Value change
-$13.2M
Number of buys
23
Number of sells
-21
Price
$0.92

Significant Holders of HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q3 2025

55 filings reported holding 405024AD2 - HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q3 2025.
HAEMONETICS CORP MASS - NOTE 2.500% 6/0 has 46 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $635M of principal .
Largest 10 bondholders include Linden Advisors LP ($163M of principal), CAMDEN ASSET MANAGEMENT L P /CA ($69.3M of principal), Invesco Ltd. ($59.2M of principal), WOLVERINE ASSET MANAGEMENT LLC ($56.3M of principal), FRANKLIN RESOURCES INC ($37.4M of principal), ZAZOVE ASSOCIATES LLC ($32M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($29.4M of principal), Wellesley Asset Management ($28.4M of principal), Calamos Advisors LLC ($22.5M of principal), and WELLS FARGO & COMPANY/MN ($21.2M of principal).
This table shows the top 46 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.